メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
長谷川 みどり
医学部・腎臓内科学
h-index
895
被引用数
16
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
1992 …
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(115)
類似のプロファイル
(6)
フィンガープリント
Midori Hasegawaが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Prospective Cohort Study
65%
Chronic Kidney Disease
59%
Kidney Function
59%
Nephropathy
58%
Proteinuria
57%
Pancreas Transplantation
53%
Creatinine
46%
Retrospective Cohort Study
46%
All Cause Mortality
44%
Renal Biopsy
43%
Cardiovascular System
41%
Urinary System
34%
ANCA Associated Vasculitis
32%
Rapidly Progressive Glomerulonephritis
30%
Pulmonary Hemorrhage
29%
Combined Therapy
28%
Immunoglobulin G4
28%
Myeloperoxidase
28%
Lipoprotein Apheresis
28%
Low-Density Lipoprotein
28%
Patient with Diabetes
28%
Lupus Nephritis
28%
Plasma Exchange
28%
Disease
28%
Cytapheresis
28%
Glomerular Filtration Rate
27%
Hemoglobin A1c
25%
Graft Survival
25%
Corticosteroid Therapy
24%
Hazard Ratio
23%
Provocation Test
23%
Glucagon
23%
Microscopic Polyangiitis
21%
Leukapheresis
21%
Granulocytapheresis
21%
Kidney Graft
20%
Proportional Hazards Model
20%
Insulin Release
19%
Vasculitis
19%
Prednisolone
19%
Ischemic Heart Disease
18%
Isotopes of Calcium
18%
Combination Therapy
18%
Hemodialysis
18%
Survival Rate
18%
Endocrine Function
17%
C-Peptide
17%
Prospective Study
16%
Interstitial Nephritis
16%
Human Study
16%
Pharmacology, Toxicology and Pharmaceutical Science
Prospective Cohort Study
100%
All Cause Mortality
57%
Chronic Kidney Failure
50%
Disease
44%
Ascites
43%
Cohort Study
39%
Kidney Disease
35%
Creatinine
31%
Troponin T
28%
Brain Natriuretic Peptide
28%
Alzheimer's Disease
28%
Vasculitis
28%
Malignant Ascites
28%
Combination Therapy
25%
Amyloid
24%
Infection
22%
Remission
20%
Inflammation
20%
Hemodialysis
19%
Kidney Failure
19%
Renin
18%
Angiotensin
18%
Adsorption
16%
Human Study
16%
Clinical Study
16%
C Reactive Protein
16%
Ischemic Heart Disease
16%
Rapidly Progressive Glomerulonephritis
15%
Amyloidosis
15%
Immunoglobulin
15%
Polysulfone
14%
Proteinuria
14%
Short Term Survival
14%
Scatter Factor
14%
Myeloperoxidase
14%
Lung Hemorrhage
14%
Immunoglobulin G4
14%
Dapagliflozin
14%
Hyperuricemia
14%
Antihypertensive Agent
14%
Kidney Polycystic Disease
14%
Cholesterol Embolism
14%
4,4' Isopropylidenediphenol
14%
Acetic Acid Derivative
14%
Neutrophil Gelatinase Associated Lipocalin
14%
Indican
14%
Transferrin Receptor
14%
Vitamin D Receptor
14%
Goodpasture Syndrome
14%
Tolvaptan
14%
Keyphrases
Dialysis Initiation
35%
Multicenter Cohort Study
30%
Incident Dialysis Patients
28%
Hemodialysis
28%
Retrospective Cohort Study
28%
Hemodialysis Patients
26%
Alzheimer's Disease
23%
All-cause Mortality
23%
Hazard Ratio
20%
Infection-related Mortality
19%
Prospective Cohort Study
17%
Removal System
17%
Confidence Interval
16%
Minimal Change Disease
14%
Remission of Proteinuria
14%
Adult Patients
14%
Potential Therapy
14%
Preoperative Hemoglobin
14%
Efficient Removal
14%
Infection Risk
14%
Cognitive Function
14%
Adsorptive Filtration
14%
Filtration System
14%
Therapeutic Apheresis
14%
Dyslipidemia
14%
Brain Amyloid
14%
Short-term Survival
14%
Primary Aldosteronism
14%
Primary Hyperparathyroidism (pHPT)
14%
Unilateral Adrenalectomy
14%
IgG4-related Kidney Disease
14%
Cholesterol
14%
Immunotactoid Glomerulopathy
14%
Usual Interstitial Pneumonia Pattern
14%
Complement C4d
14%
Transplanted Kidney
14%
Renal Hypouricemia
14%
Left Atrial Diameter
14%
Focal Segmental
14%
B-cell Depletion
14%
Serum Uric Acid
14%
Hyperuricemia
14%
Bisphenol A
14%
N-acetyl-L-tryptophan
14%
Uremic Sarcopenia
14%
Protein-bound Uremic Toxins
14%
Proteinuria
14%
Patients with Diabetes Mellitus
14%
Reticulocyte Hemoglobin Content
14%
Renal Disease
14%
